MedDataX Logo

Analysis of the Curative Effect of Salvage Surgery on Recurrent Laryngeal Carcinoma

NCT ID: NCT03604601

Last Updated: 2018-07-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

54 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-06-01

Study Completion Date

2018-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Early laryngeal cancer can be treatment by laser surgery or radiotherapy, intermediate and advanced laryngeal carcinoma mainly surgical treatment. Laryngeal cancer is at risk of recurrence after treatment, whether in surgery, laser or radiotherapy. The recurrence rate of laryngeal cancer is about 10% reported at home and abroad. Local pain, ulcers, breathing and eating difficulties caused by recurrent laryngeal cancer seriously reduce the quality of life of patients and seriously endanger their lives. Therefore, head and neck surgeons are required to make every effort to give them saving treatment in order to improve their quality of life. Prolong the patient's life.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Combination of Cryosurgey and NK Immunotherapy for Recurrent Laryngeal Cancer

NCT02849314

Recurrent Laryngeal Cancer
COMPLETED PHASE1/PHASE2

Assessment of Efficacy of Neoadjuvant Therapy in Locally Advanced Rectal Cancer

NCT06314737

Locally Advanced Rectal Carcinoma
COMPLETED

Transanal Versus Laparoscopic Total Mesorectal Excision: a Cohort

NCT05682794

Rectal Cancer
COMPLETED

The Role and Safety of Radiofrequency Ablation in Recurrent Liver Metastasis of Colorectal Cancer

NCT06609434

Colo-rectal Cancer Liver Metastasis
NOT_YET_RECRUITING NA

Multi-Site Pathological Images-Guided ViT for Oral Squamous Cell Carcinoma Recurrence Prediction

NCT06638762

Cancer of Head and Neck
COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

medical records and extracted information including age, gender, initial treatment modality of glottis cancer, recurrence time, recurrence site, histopathology, tumor grade according to World Health Organization (WHO) grade and tumor stage. Stages were defined according to the American Joint Committee on Cancer (AJCC) staging system.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Recurrent Laryngeal Carcinoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

salvage surgery

Salvage surgery hopes to control the recurrence of larynx, pharynx, fistula and neck tumor and improve the quality of life and survival rate

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* more than 18 years,
* patients with recurrent glottic laryngeal squamous cell carcinoma undergoing salvage surgery

Exclusion Criteria

* postoperative radiotherapy and chemotherapy
* loss to follow-up
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

First Affiliated Hospital, Sun Yat-Sen University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

GengLong Liu

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Genglong Liu

Role: PRINCIPAL_INVESTIGATOR

First Affiliated Hospital, Sun Yat-Sen University

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

recurrent laryngeal carcinoma

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Research on Surgery and Micro-Invasive Treatment in Recurrent Primary Liver Cancer
NCT00822562 COMPLETED NA
FOLFOX6 Totally Neoadjuvant Chemoradiation Therapy in Locally Advanced Rectal Cancer: A Real World Study
NCT02887313 UNKNOWN PHASE2
Surgery Alone Versus Neoadjuvant Treatment Followed by Surgery For MRI-defined T3 Mid-low Rectal Cancer
NCT05496270 COMPLETED
Short Course Radiotherapy Followed Intensive Chemotherapy With Delayed Surgery for Rectal Cancer With Synchronous Distant Metastasis
NCT01923987 UNKNOWN PHASE2
Preoperative (Chemo)Radiotherapy for Locally Recurrent Rectal Cancer
NCT06617052 NOT_YET_RECRUITING
Salvage Chemotherapy Versus Total Mesorectal Resection for Local Resection Rectal Cancer Patients
NCT06043999 RECRUITING NA
The Efficacy of Primary Total Mesorectal Excision (TME) Surgery Versus Neoadjuvant Chemotherapy Combined With TME Surgery in Low-risk Locally Advanced Rectal Cancer
NCT05984485 RECRUITING PHASE3
Extent of Lymph Node Dissection for Advanced Right-Sided Colon Cance
NCT06986538 NOT_YET_RECRUITING NA
Early Recurrent Nasopharyngeal Cancer: the Effect of Surgery vs IMRT
NCT04215510 NOT_YET_RECRUITING PHASE3
Efficacy and Safety Study of Neoadjuvant in Treating Patients With Resectable Local Recurrent Rectal Cancer
NCT01271192 UNKNOWN NA
Combination of Cryosurgey and NK Immunotherapy for Recurrent Tongue Cancer
NCT02849379 COMPLETED PHASE1/PHASE2
Stereotactic Body Radiation Therapy for Unresectable Locally Recurrent Rectal Cancer
NCT07297004 RECRUITING PHASE2
A Translational Study for Locoregional Recurrence of T4 Colon Cancer
NCT06958926 RECRUITING
Surgical Treatment and Molecular Marker Exploration of Locally Recurrent Colorectal Cancer
NCT06114420 RECRUITING
Effects of Different Treatment for Anorectal Function of Patients With Rectal Cancer
NCT05671809 NOT_YET_RECRUITING
Gasless Single-port Laparoscopic-assisted Radical Resection for Rectal Carcinoma
NCT03318185 UNKNOWN NA
Gastric-type Endocervical Adenocarcinoma: a Population-based Cohort Study
NCT06897306 COMPLETED
High Dose Radiotherapy for the Treatment of Rectal Cancer
NCT03541304 COMPLETED
Second-line Regimen Combined With Radiotherapy Versus Without Radiotherapy in Patients With Locally Advanced/Oligometastatic ICC After Failure of First-line Treatment：an Open-label, Randomized, Controlled Phase II Clinical Study
NCT06946849 NOT_YET_RECRUITING PHASE2
Functional Organ Preservation Surgery
NCT01330056 COMPLETED NA
PET on Surgery for Loco-regionally Recurrent Colorectal Cancer
NCT05924282 COMPLETED
Delayed Systemic Therapy Following Destructive Local Treatment of Pulmonary Oligometastases After No Evidence of Disease (NED) in Colorectal Cancer.
NCT06778382 RECRUITING PHASE2
RFA Combined With Chemotherapy for Unresectable Cholangiocarcinoma
NCT05028439 COMPLETED NA
Feasibility and Safety of Robotic Assisted Proximal Gastrectomy With Double-flap Technique for Proximal Early Gastric Cancer
NCT05892289 RECRUITING NA
Microwave Ablation for Pulmonary Metastases From Colorectal Cancer
NCT02502630 COMPLETED NA